{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:37:47Z","timestamp":1775083067760,"version":"3.50.1"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>\n                    In medullary thyroid carcinoma (MTC), skeletal metastases are present in 19% of patients at initial diagnosis and increase up to 29% during follow-up, predominantly involving the spine and pelvis. We describe 2 patients of metastatic MTC illustrating divergent lesion morphologies: one exhibiting sclerotic bone metastases and the other displaying marrow and lytic lesions. The lytic and marrow-based metastases demonstrated more avidity for [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG PET\/CT, whereas [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-DOTA-FAPI-04 PET\/CT provided enhanced visualization of the sclerotic lesions. This dichotomous tracer behaviour underscores the importance of tailoring PET agent selection to lesion morphology, potentially optimizing diagnostic accuracy and guiding individualized management strategies.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006206","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:00:22Z","timestamp":1764082822000},"page":"e338-e339","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dichotomous Uptake Pattern on [18F]F-FDG and [68Ga]Ga-DOTA-FAPI-04 PET\/CT in Lytic, Sclerotic and Marrow Metastatic Skeletal Lesions in Medullary Thyroid Carcinoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Shyam Kumar","family":"Ravada","sequence":"first","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel"},{"name":"Homi Bhabha National Institute, Mumbai, MH, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul V.","family":"Parghane","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel"},{"name":"Homi Bhabha National Institute, Mumbai, MH, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel"},{"name":"Homi Bhabha National Institute, Mumbai, MH, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"R1-20260401","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1210\/jc.2016-2815","article-title":"Bone metastases and skeletal-related events in medullary thyroid carcinoma","volume":"101","author":"Xu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20260401","doi-asserted-by":"crossref","first-page":"dgaa077","DOI":"10.1210\/clinem\/dgaa077","article-title":"Bone metastases in medullary thyroid carcinoma: high morbidity and poor prognosis associated with osteolytic morphology","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20260401","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00259-006-0141-3","article-title":"FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy","volume":"33","author":"Israel","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20260401","doi-asserted-by":"crossref","first-page":"117426","DOI":"10.1016\/j.bone.2025.117426","article-title":"Superiority of 68Ga-DOTA-FAPI-04 PET\/CT to 18F-FDG PET\/CT in the evaluation of different cancers with bone metastases","volume":"196","author":"Guo","year":"2025","journal-title":"Bone"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:00:51Z","timestamp":1775077251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006206","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"2025-06-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}